<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="16" ids="53704">APO</z:chebi>-1 antigen as defined by the mouse monoclonal antibody anti-<z:chebi fb="16" ids="53704">APO</z:chebi>-1 was previously found to be expressed on the cell surface of activated human T and B lymphocytes and a variety of malignant human lymphoid cell lines </plain></SENT>
<SENT sid="1" pm="."><plain>Cross-linking of the <z:chebi fb="16" ids="53704">APO</z:chebi>-1 antigen by anti-<z:chebi fb="16" ids="53704">APO</z:chebi>-1 induced programmed cell <z:hpo ids='HP_0011420'>death</z:hpo>, <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, of <z:chebi fb="16" ids="53704">APO</z:chebi>-1 positive cells </plain></SENT>
<SENT sid="2" pm="."><plain>To characterize the <z:chebi fb="16" ids="53704">APO</z:chebi>-1 cell surface molecule and to better understand its role in induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, the <z:chebi fb="16" ids="53704">APO</z:chebi>-1 protein was purified to homogeneity from membranes of SKW6.4 B lymphoblastoid cells by solubilization with <z:chebi fb="0" ids="9177">sodium deoxycholate</z:chebi>, affinity chromatography with anti-<z:chebi fb="16" ids="53704">APO</z:chebi>-1 antibody, and reversed phase high performance liquid chromatography </plain></SENT>
<SENT sid="3" pm="."><plain>Each purification step was followed by an <z:chebi fb="16" ids="53704">APO</z:chebi>-1-specific solid phase enzyme-linked immunosorbent assay using the monoclonal antibody anti-<z:chebi fb="16" ids="53704">APO</z:chebi>-1 </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:chebi fb="0" ids="8984">sodium dodecyl sulfate</z:chebi>-<z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gel electrophoresis, the <z:chebi fb="16" ids="53704">APO</z:chebi>-1 antigen was found to be a membrane <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> of 48-kDa </plain></SENT>
<SENT sid="5" pm="."><plain>Endoproteinase-cleaved <z:chebi fb="7" ids="16670">peptides</z:chebi> of the <z:chebi fb="16" ids="53704">APO</z:chebi>-1 protein were subjected to amino acid sequencing, and corresponding oligonucleotides were used to identify a full-length <z:chebi fb="16" ids="53704">APO</z:chebi>-1 cDNA clone from an SKW6.4 cDNA library </plain></SENT>
<SENT sid="6" pm="."><plain>The deduced amino acid sequence of <z:chebi fb="16" ids="53704">APO</z:chebi>-1 showed sequence identity with the Fas antigen, a cysteine-rich transmembrane protein of 335 amino acids with significant similarity to the members of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor/nerve growth factor receptor superfamily </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:chebi fb="16" ids="53704">APO</z:chebi>-1 antigen was expressed upon transfection of <z:chebi fb="16" ids="53704">APO</z:chebi>-1 cDNA into BL60-P7 Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells and conferred sensitivity towards anti-<z:chebi fb="16" ids="53704">APO</z:chebi>-1-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> to the transfectants </plain></SENT>
</text></document>